San Francisco, California, July 11, 2017: Hectic lifestyle of people across the globe is the core cause of panic disorders among several age groups, states TMR Research in a research report. The report is titled, “Panic Disorders Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025.”
Panic disorders are also termed as anxiety disorders which deals with unexpected and recurrent panic attacks. These type of attacks occur suddenly and can also have a huge impact on a person’s health if left untreated. Thus, many therapeutics and drugs have been introduced for treating the patients who are suffering from panic disorders worldwide. The growing demand for effective drugs and the increasing awareness among consumers relating to the availability of drugs and therapeutics is expected to encourage the progress of the global market for panic disorders in the years ahead.
The key market players are concentrating on educating people regarding the severe repercussions of panic disorders when left untreated or not treated properly. This expected to instigate the growth of the market in the years yet to come. Additionally, the rising emphasis of companies on the development of novel and advanced products through investments in research and development activities is expected to present lucrative growth opportunities to the market players. The growing preference of patients who are spending on extensively on healthcare is further anticipated to accelerate the progress of the market in the coming years.
With significant rise in the level of competition, the companies operating in the market are anticipated to roll up their sleeves and enhance their marketing strategies. The growth of the market is expected to be encouraged with product portfolio expansion and growing demand for panic disorder drugs and therapeutics from the developed countries. Furthermore, the publicity strategies that are being adopted by the vendors and the enhanced distribution networks are some noteworthy aspects that likely to bolster the growth of the global market for panic disorders in the near future.
The market is gaining further impetus owing to the growing number of cases of panic or anxiety disorders due to hectic lifestyle. The availability of good treatment and enhancing awareness is expected to act as major aspects boosting the growth of the market in the years to come. Region-wise, the market is anticipated to be led by North America owing to the prevalence of numerous players in the market and the availability of therapeutics. Asia Pacific is expected to catch up in the competition. The core players present are Pfizer, Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd., Neurocrine Biosciences, Inc., Neurocrine Biosciences, Inc., and Boehringer Ingelheim GmbH, among others.